Clinical Trial Update: The Rosuvastatin In TrAnsplant Recipients Study [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 clinical trial assessing rosuvastatin in transplant recipients with hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: University of Oslo School of Pharmacy | Conditions: Disorder Related to Renal Transplantation, Hypercholesterolemia | Phase 4 | Status: COMPLETED